Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
InnoCare Pharma Ltd. ( (HK:9969) ) just unveiled an announcement.
InnoCare Pharma Limited has announced a board meeting scheduled for May 13, 2025, to review and approve the company’s unaudited first quarterly results for the period ending March 31, 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting its market position and stakeholder interests.
More about InnoCare Pharma Ltd.
InnoCare Pharma Limited is a pharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative therapies for the treatment of cancer and autoimmune diseases.
YTD Price Performance: 65.69%
Average Trading Volume: 12,796,074
Technical Sentiment Signal: Sell
Current Market Cap: HK$15.17B
Find detailed analytics on 9969 stock on TipRanks’ Stock Analysis page.